コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ULITE and SimulTRAC-SNB) for B12 analysis in human milk.
2 abor intensive and requires large volumes of human milk.
3 ere is a need to quantify arsenic species in human milk.
4 health benefits that are similar to those of human milk.
5 al needs of these infants from the intake of human milk.
6 of an infant exclusively from the intake of human milk.
7 fluence the bacterial communities inhabiting human milk.
8 lactoglobulin (BLG), which is not present in human milk.
9 are found in premature infants fed fortified human milk.
10 des are the third most abundant component in human milk.
11 ld standard for measuring the fat content of human milk.
12 ccharides are the third largest component of human milk.
13 ecretory antibodies and prebiotic factors in human milk.
14 establish the profile of boron metabolism in human milk.
15 in most human mucosal secretions, including human milk.
16 nly the complexed matriptase was detected in human milk.
17 idly from the chylomicrons of the blood into human milk.
18 f dietary fatty acids from chylomicrons into human milk.
19 significance of oligosaccharide variation in human milk.
20 d significantly less phosphocholine than did human milk.
21 able in secretions such as saliva, tears and human milk.
22 moiety in milk) and phosphocholine than did human milk.
23 palmitic and oleic acids similar to those of human milk.
24 hocholine and glycerophosphocholine exist in human milk.
25 low birth weight infants discharged home on human milk.
26 y 6% of infants were discharged on exclusive human milk.
27 Most importantly, this activity is unique to human milk.
28 l roles that sIgA and its components play in human milk.
29 uisition and that this activity is unique to human milk.
30 undant and structurally diverse component in human milk.
31 of two octasaccharide antigens isolated from human milk, 1 and 2, and their corresponding allyl glyco
32 d the top contributors were formula (71.7%), human milk (22.9%), and commercial baby foods (2.2%).
35 rkup and is useful in defining variations in human milk acidic oligosaccharides and investigating the
38 sialylated acidic oligosaccharides of pooled human milk agreed with the results of previous studies e
39 ipitation studies also detected the PRLBP in human milk albeit at lower concentrations than found in
40 benefits observed in infants fed unfortified human milk also are found in premature infants fed forti
42 addressing DHA intakes by lactating women or human milk amounts of DHA at levels above those typical
47 oic acid (PFOA), analysed by HPLC-ESI-MS, in human milk and food samples from the city of Siena and i
48 method for the determination of parabens in human milk and food with relative recoveries in the rang
50 cated that differences in the composition of human milk and infant formula yield benefits in cognitiv
52 mixture of N-glycoproteins from unprocessed human milk and O-glycoproteins from very-low-density-lip
53 -containing immunomodulatory glycan found in human milk and on parasitic helminths, improves glucose
54 cto-N-fucopentaose III (LNFPIII) is found in human milk and on the Th2 driving helminth parasite Schi
55 matrix interferences by haptocorrin (HC) in human milk and serum show that past analyses of vitamin
56 ted flame retardants that have been found in human milk and serum throughout the world, but have rece
58 ublished data on whether it is detectable in human milk and therefore consumed by breastfed infants.
59 determine whether adiponectin is present in human milk and to characterize maternal factors associat
60 bnormalities with insulin and adiponectin in human milk and to compare the concentrations of these ho
61 ontaining at least one trans double bond) in human milk and to identify relations between individual
62 is, but not A or B antigens, were present in human milk and were responsible for blocking NV binding
63 ficantly more bioavailable GABA than cow and human milks and are able to activate GABArho receptors.
64 low birth weight infants discharged on "any human milk") and the independent variables (nurse work e
66 harides found on helminths also are found in human milk, and both helminths and milk have been shown
68 o find that lysozyme from chicken egg white, human milk, and human neutrophils and RNase A from bovin
76 oclast formation, the expression of TRAIL in human milk as a function of vitamin D status in mothers
79 murine exudates, regenerating planaria, and human milk as well as macrophages that stimulate tissue
82 ion and immunological protection provided in human milk at discharge is an issue of health care quali
85 d LCP supplementation in amounts typical for human milk (based on local and worldwide surveys) in a l
86 c digestion of lipids and some proteins from human milk but did affect lactoferrin and alpha-lactalbu
87 oic acid (DHA) and arachidonic acid (ARA) in human milk but not in infant formula, coupled with lower
88 incomplete about not only the composition of human milk, but also the maternal nutritional needs to s
89 itrypsin and antichymotrypsin are present in human milk, but little is known about their roles in pro
90 , immortalized mammary epithelial cells, and human milk, but not in cultured fibroblasts nor in fibro
91 an antimicrobial protein highly expressed in human milk, but not ruminant milk, and is thought to hel
92 ve a strong effect on the mineral content of human milk, but physiologic changes in milk and the infa
93 cates that metabolic hormones are present in human milk, but, to our knowledge, no studies have inves
97 BCDs), and tetrabromobisphenol-A (TBBP-A) in human milk collected in 2010-2011 from 10 first-time mot
98 r pasteurization has been reported to modify human milk composition and structure by inactivating bil
118 uman milk is protective against NEC, and the human milk factor erythropoietin (Epo) has been shown to
119 l-in-water IF emulsion was formulated with a human milk fat analogue enriched with docosahexaenoic ac
120 derived from fat, we estimated from the TFA human milk fat data that TFA intake of Canadian breastfe
121 tween the percentage of TFAs in the diet and human milk fat established by Craig-Schmidt et al, and a
122 therefore examined the effect of recombinant human milk fat globule-EGF factor 8 (rhMFG-E8) in mitiga
126 om effects on neurodevelopment solely due to human milk fatty acids is complex, particularly when neu
127 gy density, will aid in understanding of the human milk fatty acids that best support neurological de
133 provide an overview on the use of exclusive human milk feeding and the utility of this approach in p
139 has little or no effect on many nutrients in human milk; for others, human milk may not be designed a
142 n/100 mL of breast milk through a commercial human milk fortifier; n = 30) or a higher-protein group
143 he composition and structures of TAGs in the human milk from mothers with different food choices and
146 haride samples equivalent to 1 microliter of human milk give optimum chromatographic separation and r
147 hese same HMOs established using the shotgun human milk glycan microarray (HM-SGM-v2) showed fair-to-
148 gun glycan microarray prepared from isolated human milk glycans (HMGs), and our studies on their reco
149 the structures of soluble glycans within the human milk glycome by matching predicted structures base
150 tment of HT-29 colonic epithelial cells with human milk HA at physiologic concentrations results in t
151 nt of cultured colonic epithelial cells with human milk HA enhances resistance to infection by the en
155 late that erythropoietin (EPO), a hormone in human milk, has a role in the prevention of HIV transmis
156 ferrin (Lf), a major iron-binding protein in human milk, has been suggested to have multiple biologic
163 In a recent study on the TFA content of human milk in a sizable group of mothers at the sixth we
164 The 42-kDa glycopolypeptide purified from human milk in CA inhibitor affinity chromatography share
165 onstrate the presence of both PQQ and IPQ in human milk in nanomolar to micromolar concentrations.
166 However, the proportion of (unsupplemented) human milk in the neonatal diet was significantly positi
167 nalyses, the proportion of enteral intake as human milk in the neonatal period was inversely related
172 higher whole-body bone mass associated with human milk intake, despite its very low nutrient content
175 h it is known that the fatty acid profile of human milk is altered by diet, the rapidity with which t
185 this review we show that the composition of human milk is rather variable and is dependent on factor
189 -chain n-3 fatty acid in plasma, tissues, or human milk is to supplement with the fatty acid of inter
191 on impacted the microstructure of undigested human milk, its gastrointestinal disintegration and tend
197 impact of pasteurization on the digestion of human milk may have nutritional relevance in vivo and po
198 on many nutrients in human milk; for others, human milk may not be designed as a primary nutritional
203 findings reveal an unrecognized function of human milk, namely, its capacity to influence neonatal m
205 a-3) fatty acids from the maternal diet into human milk occurs with little interconversion of 18:2n-6
207 we describe a method for the quantitation of human milk oligosaccharide (HMO) structures employing LC
208 Conjugates of PADRE covalently linked to the human milk oligosaccharide, lacto-N-fucopentose II or a
209 easured for natural abundance samples of the human milk oligosaccharides "lacto-N-fucopentaose" (LNF-
214 es of structurally heterogeneous mixtures of human milk oligosaccharides (HMOs) and bovine milk oligo
216 of rapidly identifying interactions between human milk oligosaccharides (HMOs) and their protein rec
219 ption, bacteria were grown in a medium using human milk oligosaccharides (HMOs) as the only carbon so
220 obtain a treated milk with 7.0 g/L GOS - the human milk oligosaccharides (HMOs) concentration is betw
221 ed whether differences in the composition of human milk oligosaccharides (HMOs) correlate with infant
225 olute quantitation method for measuring free human milk oligosaccharides (HMOs) in milk samples was d
228 collection of 60 asymmetric, multiantennary human milk oligosaccharides (HMOs), which were used to d
231 few decades it has become apparent that the human milk oligosaccharides are composed of thousands of
234 ive and quantitative individual variation of human milk oligosaccharides, a sensitive method for rout
237 tures that have prebiotic effects similar to human-milk oligosaccharides include galacto-oligosacchar
238 ated the impact of pasteurization of preterm human milk on its gastrointestinal kinetics of lipolysis
239 the present study, we examined the effect of human milk on the H. influenzae IgA1 protease and Hap ad
240 is available on B vitamin concentrations in human milk or on how they are affected by maternal B vit
242 ned specifically to mimic the composition of human milk or the functional aspects of human milk feedi
249 towards specific IgE being detected to more human milk peptides in those infants who did not respond
250 in] and the corresponding, highly homologous human milk peptides were labelled with sera from 15 brea
252 -G, immunoglobulin-M, and an undiluted crude human milk preparation were tested in vitro for their ab
253 ndividual and interindividual variability of human milk protein and energy content potentially contri
256 n the neonate gut and abundant in bovine and human milk provides a basis for age-restricted tropism a
258 esembling non-digestible oligosaccharides in human milk reduce the development of atopic disorders.
260 On the basis of scientific insights from human-milk research, a specific mixture of nondigestible
261 up in comparing the gastric digestion of raw human milk (RHM) with pasteurized human milk (PHM).
264 The quantitation method was applied to 20 human milk samples to determine the variations in HMO co
266 as further tested by analyzing two Norwegian human milk samples where arsenobetaine, dimethylarsinate
268 optimised method, applied to the analysis of human milk samples, included their dilution (1:5) with w
271 he nondigestible oligosaccharides present in human milk show a clear bifidogenic effect on the gut mi
272 ir host mucosal surfaces may be inhibited by human milk sialyloligosaccharides, but testing this hypo
274 (European Childhood Obesity Trial, Norwegian Human Milk Study, and Prevention of Coeliac Disease) tha
275 ghlight the importance of structure specific human milk substitutes and the careful selection of the
276 targeted preventive measures in addition to human milk, such as prebiotics and probiotics, to the ma
278 ly fucosylated neutral oligosaccharides from human milk that are based on the iso-lacto-N-octaose cor
279 the protein cost of non-protein nitrogen in human milk, the recommended increment in protein is abou
280 preserved the original volatile compounds of human milk, this novel process may be an alternative to
282 infant on complementary foods in addition to human milk to meet iron and zinc requirements after 6 mo
283 corpus callosum; every additional 10 days of human milk use were associated with a three weeks or gre
286 essure treatments on the volatile profile of human milk was less intense than that caused by HoP.
289 study, using active matriptase isolated from human milk, we demonstrate that matriptase is able to cl
291 or constituent of an innate immune system of human milk whereby the mother protects her infant from e
294 , and HB-2) derived from cells cultured from human milk, with three breast cancer cell lines (MCF-7,
295 these fatty acids increased significantly in human milk within 6 h of consumption of the test formula
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。